InvestorsHub Logo
Followers 10
Posts 1665
Boards Moderated 0
Alias Born 03/25/2004

Re: None

Thursday, 07/14/2011 7:16:46 PM

Thursday, July 14, 2011 7:16:46 PM

Post# of 4675
OT: Something to watch while you wait for AMY -

SNGX.ob - Do your DD -

12 July, 10 Hot Bio-tech stocks (The Street):
"Soligenix(SNGX.OB)

The event: Phase III study of orBec in graft-versus-host disease.

The timeline: Top-line results expected in the second half of the year.

The stakes: FDA rejected orBec in 2007, instructing Soligenix to run a confirmatory, phase III study in graft-versus-host disease (GVHD). OrBec is an oral (pill) reformulation of a well-known topical steroid that can be delivered directly to the gut, where it's most needed to help patients with GI GVHD."

Phase III study due this year, although as you see from above, the pill was previously rejected. If approved, share prices of $1.50 to $2.50 reported. Keep it on your watch list.

8K PM today - Two top Execs. give up bonuses for performance pay instead. Up 14% today likely on i2 July article and on 8K news leak.

47% ownership by insiders.